Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidia Giraudo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Immunotherapy|August 28, 2015
Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectivesLidia Giraudo, Loretta Gammaitoni, Michela Cangemi, et al.
Expert Opinion on Biological Therapy|May 20, 2014
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospectiveLoretta Gammaitoni, Valeria Leuci, Giulia Mesiano, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapyValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Expert Opinion on Biological Therapy|April 17, 2012
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumorsGiulia Mesiano, Maja Todorovic, Loretta Gammaitoni, et al.
Cancers|June 2, 2021
Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma ModelsIlenia Iaia, Loretta Gammaitoni, Giulia Cattaneo, et al.
Expert Opinion on Biological Therapy|December 18, 2014
Adoptive immunotherapy against sarcomasGiulia Mesiano, Valeria Leuci, Lidia Giraudo, et al.
Oncoimmunology|November 6, 2018
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapyGiulia Mesiano, Giovanni Grignani, Erika Fiorino, et al.
British Journal of Haematology|September 26, 2022
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriersPaola Circosta, Chiara Donini, Susanna Gallo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 AntibodyMartina Sanlorenzo, Igor Vujic, Arianna Floris, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2012
Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriersMaja Todorovic, Giulia Mesiano, Loretta Gammaitoni, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Immunotherapy|August 28, 2015
Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectivesLidia Giraudo, Loretta Gammaitoni, Michela Cangemi, et al.
Expert Opinion on Biological Therapy|May 20, 2014
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospectiveLoretta Gammaitoni, Valeria Leuci, Giulia Mesiano, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapyValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Expert Opinion on Biological Therapy|April 17, 2012
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumorsGiulia Mesiano, Maja Todorovic, Loretta Gammaitoni, et al.
Cancers|June 2, 2021
Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma ModelsIlenia Iaia, Loretta Gammaitoni, Giulia Cattaneo, et al.
Expert Opinion on Biological Therapy|December 18, 2014
Adoptive immunotherapy against sarcomasGiulia Mesiano, Valeria Leuci, Lidia Giraudo, et al.
Oncoimmunology|November 6, 2018
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapyGiulia Mesiano, Giovanni Grignani, Erika Fiorino, et al.
British Journal of Haematology|September 26, 2022
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriersPaola Circosta, Chiara Donini, Susanna Gallo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 AntibodyMartina Sanlorenzo, Igor Vujic, Arianna Floris, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2012
Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriersMaja Todorovic, Giulia Mesiano, Loretta Gammaitoni, et al.
Pageof 2